Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the effectiveness and safety of indacaterol with salmeterol /fluticasone propionate treatment in patients with moderate chronic obstructive pulmonary disease wh...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT07190209 · Chronic Obstructive Pulmonary Disease
NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07073950 · Chronic Obstructive Pulmonary Disease, Hyperinflation
NCT07509606 · Chronic Obstructive Pulmonary Disease (COPD), Whole Body Vibration
Novartis Investigative Site
Caba, Argentina
Novartis Investigative Site
Buenos Aires, Buenos Aires
Novartis Investigative Site
Buenos Aires, Buenos Aires
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions